leisure time
Previous article:
As demand for Covid shots wanes, Moderna seeks its next success
Next article: Readout Newsletter: Ironwood, Pfizer, FogPharma updates
Next article: Readout Newsletter: Ironwood, Pfizer, FogPharma updates
focus
focus
-
ALS groups 'won't be played again' by the FDA, drug sponsors
2025-09-29 22:46 -
RSV vaccines may be linked to small increased risk of developing GBS
2025-09-29 22:33 -
FogPharma raises $145 million in rare Series E round
2025-09-29 21:27 -
McConnell is warmly embraced by Kentucky Republicans amid questions about his health
2025-09-29 21:20 -
Kristina Burow of ARCH Venture Partners shares her next big bets STAT
2025-09-29 21:11 -
Failure, not just success, should guide future doctors
2025-09-29 20:57